diversity and inclusion
-
Inato Snags $20M to Make Clinical Trials More Diverse & Accessible
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they’re interested.
-
Kaiser Nurses Ratify New Contract That Raises Wages by 22.5% And Improves Staffing
About 21,000 Kaiser Permanente nurses in Northern California ratified a new four-year contract — one that includes provisions for a 22.5% wage increase, improved staffing and more. The contract’s approval comes about two weeks after Kaiser reached an agreement with California Nurses Association to avert what would have been the biggest private sector nurses strike in American history.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Inside a VC Firm’s Strategy to Advance Equity and Diversity in Health Tech Innovation
Third Culture Capital (3CC) is a venture capital firm founded with the mission to foster more equity and diversity in health technology innovation. 3CC Founder and Managing Partner said the firm is intentional about connecting to the “unique lived experiences” of the founders it invests in, as this approach ensures that it is not just checking its diversity boxes.
-
MedCity Influencers, BioPharma
Key metrics for successful D&I in the drug development lifecycle
Taking steps to eliminate health disparities among people of color and ensuring diversity throughout the development cycle should be a strategic goal for all. Medical Affairs can be the change agents within their organizations to help with this push.
-
MedCity Influencers, Pharma, Artificial Intelligence, Health Tech
How is AI moving the needle in the pharmaceutical industry?
Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.
-
Restoring trust in clinical trials among Black communities
Whether seeking to overcome ongoing hesitation of the Covid-19 vaccine or searching for moonshot cancer solutions, whatever the healthcare need demands, seeking results for diverse populations must be a priority.
-
Hospitals, MedCity Influencers
Engaging communities of color is crucial to achieving health equity and cultural proficiency in healthcare
Reaching out to and connecting with communities of color is a moral imperative. It’s a business imperative. For the healthcare system, it is no longer an option in an increasingly multicultural society.
-
MedCity Influencers, Community
Prioritizing the health needs of the LGBTQ+ community
Not only is the community at a higher risk of severe Covid-19 outcomes, but LGBTQ+ people are also suffering from mental health issues associated with social isolation.
-
826 reasons for shareholders to be happy
I am a venture capitalist in California and believe that the state’s SB 826 bill that just passed requiring public companies headquartered in the state to have women on corporate boards will be a boon for shareholders. Here’s why.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.